Development of polycystic kidney disease in juvenile cystic kidney mice: Insights into pathogenesis, ciliary abnormalities, and common features with human disease

Journal of the American Society of Nephrology

Volumn 17, Issue 10, 2006, Pages 2821-2831

  Smith, Laurie A ^a   Bukanov, Nikolay O ^a   Husson, Hervé ^a   Russo, Ryan J ^a   Barry, Tiffany C ^a   Taylor, Ava L ^a   Beier, David R ^b   Ibraghimov Beskrovnaya, Oxana ^a  

^a GENZYME CORPORATION   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENDER; GENE; GENE OVEREXPRESSION; GONADECTOMY; HENLE LOOP; JCK GENE; JUVENILE CYSTIC KIDNEY DISEASE; KIDNEY CILIARY EPITHELIUM; KIDNEY COLLECTING TUBULE; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY EPITHELIUM; KIDNEY POLYCYSTIC DISEASE; MALE; MOLECULAR MECHANICS; MOUSE; NEPHRON; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRUCTURE ACTIVITY RELATION; WILD TYPE;

EID: 33749235323     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006020136     Document Type: Article

References (50)

1. Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993
2. Wilson PD: Polycystic kidney disease: New understanding in the pathogenesis. InI J Biochem Cell Biol 36: 1868-1873, 2004
3. Calvet JP, Grantham JJ: The genetics and physiology of polycystic kidney disease. Semin Nephrol 21: 107-123, 2001
4. Cowley BD Jr: Recent advances in understanding the pathogenesis of polycystic kidney disease: Therapeutic implications. Drugs 64: 1285-1294, 2004
5. Torres VE, Harris PC: Autosomal dominant polycystic kidney disease. Nefrologia 23[Suppl 1]: 14-22, 2003
6. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995
7. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S: PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996
8. Grantham JJ: Mechanisms of progression in autosomal dominant polycystic kidney disease. Kidney Int Suppl 63: S93-S97, 1997
9. Bacallao RL, Carone FA: Recent advances in the understanding of polycystic kidney disease. Curr Opin Nephrol Hypertens 6: 377-383, 1997
10. Russo RJ, Husson H, Joly D, Bukanov NO, Patey N, Knebelmann B, Ibraghimov-Beskrovnaya O: Impaired formation of desmosomal junctions in ADPKD epithelia. Histochem Cell Biol 124: 487-497, 2005
11. Bukanov NO, Husson H, Dackowski WR, Lawrence BD, Clow PA, Roberts BL, Klinger KW, Ibraghimov-Beskrovnaya O: Functional polycystin-1 expression is developmentally regulated during epithelial morphogenesis in vitro: Down-regulation and loss of membrane localization during cystogenesis. Hum Mol Genet 11: 923-936, 2002
12. Husson H, Manavalan P, Akmaev VR, Russo RJ, Cook B, Richards B, Barberio D, Liu D, Cao X, Landes GM, Wang CJ, Roberts BL, Klinger KW, Grubman SA, Jefferson DM, Ibraghimov-Beskrovnaya O: New insights into ADPKD molecular pathways using combination of SAGE and microarray technologies. Genomics 84: 497-510, 2004
13. Roitbak T, Ward CJ, Harris PC, Bacallao R, Ness SA, Wandinger-Ness A: A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell 15: 1334-1346, 2004
14. Delmas P: The gating of polycystin signaling complex. Biol Res 37: 681-691, 2004
15. Boletta A, Germino GG: Role of polycystins in renal tubulogenesis. Trends Cell Biol 13: 484-492, 2003
16. Qian Q, Harris PC, Torres VE: Treatment prospects for autosomal-dominant polycystic kidney disease. Kidney Int 59: 2005-2022, 2001
17. Torres VE: Vasopressin antagonists in polycystic kidney disease. Kidney Int 68: 2405-2418, 2005
18. Sweeney WE, Hamahira K, Sweeney J, Garcia-Gatrell M, Frost P, Avner ED: Combination treatment of PKD utilizing dual inhibition of EGF-receptor activity and ligand bioavailability. Kidney Int 64: 1310-1319, 2003
19. Guay-Woodford LM: Murine models of polycystic kidney disease: Molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-F1049, 2003
20. Gattone VH, Wang X, Harris PC, Torres VE: Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med 9: 1323-1326, 2003
21. Sweeney WE, Chen Y, Nakanishi K, Frost P, Avner ED: Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int 57: 33-40, 2000
22. Torres VE, Sweeney WE, Wang X, Qian Q, Harris PC, Frost P, Avner ED: EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney Int 64: 1573-1579, 2003
23. Otto EA, Schermer B, Obara T, O'Toole JF, Hiller KS, Mueller AM, Ruf RG, Hoefele J, Beekmann F, Landau D, Foreman JW, Goodship JA, Strachan T, Kispert A, Wolf MT, Gagnadoux MF, Nivet H, Antignac C, Walz G, Drummond IA, Benzing T, Hildebrandt F: Mutations in INVS encoding inversin cause nephronophthisis type 2, linking renal cystic disease to the function of primary cilia and left-right axis determination. Nat Genet 34: 413-420, 2003
24. Ong AC, Wheatley DN: Polycystic kidney disease: The ciliary connection. Lancet 361: 774-776, 2003
25. Pazour GJ: Intraflagellar transport and cilia-dependent renal disease: The ciliary hypothesis of polycystic kidney disease. J Am Soc Nephrol 15: 2528-2536, 2004
26. Liu S, Lu W, Obara T, Kuida S, Lehoczky J, Dewar K, Drummond IA, Beier DR: A defect in a novel Nek-family kinase causes cystic kidney disease in the mouse and in zebrafish. Development 129: 5839-5846, 2002
27. Atala A, Freeman MR, Mandell J, Beier DR: Juvenile cystic kidneys (jck): A new mouse mutation which causes polycystic kidneys. Kidney Int 43: 1081-1085, 1993
28. Mahjoub MR, Trapp ML, Quarmby LM: NIMA-related kinases defective in murine models of polycystic kidney diseases localize to primary cilia and centrosomes. J Am Soc Nephrol 16: 3485-3489, 2005
29. Iakoubova O, Dushkin H, Pacella L, Beier DR: Genetic analysis of modifying loci on mouse chromosome 1 that affect disease severity in a model of recessive PKD. Physiol Genomics 1: 101-105, 1999
30. Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM: Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Am J Kidney Dis 39: 1078-1087, 2002
31. Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, Ibraghimov-Beskrovnaya O, Klinger K, Sandford R: Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol 11: 814-827, 2000
32. Kleymenova E, Ibraghimov-Beskrovnaya O, Kugoh H, Everitt J, Xu H, Kiguchi K, Landes G, Harris P, Walker C: Tuberin-dependent membrane localization of polycystin-1: A functional link between polycystic kidney disease and the TSC2 tumor suppressor gene. Mol Cell 7: 823-832, 2001
33. Ibraghimov-Beskrovnaya O, Bukanov NO, Donohue LC, Dackowski WR, Klinger KW, Landes GM: Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum Mol Genet 9: 1641-1649, 2000
34. Avner ED: Epithelial polarity and differentiation in polycystic kidney disease. J Cell Sci Suppl 17: 217-222, 1993
35. Torres VE, Sweeney WE Jr, Wang X, Qian Q, Harris PC, Frost P, Avner ED: Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney Int 66: 1766-1773, 2004
36. Yamaguchi T, Nagao S, Wallace DP, Belibi FA, Cowley BD, Felling JC, Grantham JJ: Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63: 1983-1994, 2003
37. Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 2004
38. Kovacs J, Gomba S: Analysis of the role of apoptosis and cell proliferation in renal cystic disorders. Kidney Blood Press Res 21: 325-328, 1998
39. Grantham JJ, Geiser JL, Evan AP: Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int 31: 1145-1152, 1987
40. Lin F, Satlin LM: Polycystic kidney disease: The cilium as a common pathway in cystogenesis. Curr Opin Pcdiatr 16: 171-176, 2004
41. Watnick T, Germino G: From cilia to cyst. Nat Genet 34: 355-356, 2003
42. Wloga D, Camba A, Rogowski K, Manning G, Jerka-Dziadosz M, Gaertig J: Members of the NIMA-related kinase family promote disassembly of cilia by multiple mechanisms. Mol Biol Cell 17: 2799-2810, 2006
43. Stewart JH: End-stage renal failure appears earlier in men than in women with polycystic kidney disease. Am J Kidney Dis 24: 181-183, 1994
44. Stringer KD, Komers R, Osman SA, Oyama TT, Lindsley JN, Anderson S: Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 68: 1729-1739, 2005
45. Lager DJ, Qian Q, Bengal RJ, Ishibashi M, Torres VE: The pck rat: A new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int 59: 126-136, 2001
46. Devuyst O, Burrow CR, Smith BL, Agre P, Knepper MA, Wilson PD: Expression of aquaporiris-1 and -2 during nephrogenesis and in autosomal dominant polycystic kidney disease. Am J Physiol 271: F169-F183, 1996
47. Baert L: Hereditary polycystic kidney disease (adult form): A microdissection study of two cases at an early stage of the disease. Kidney Int 13: 519-525, 1978
48. Orellana SA, Sweeney WE, Neff CD, Avner ED: Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int 47: 490-499, 1995
49. Sweeney WE Jr, Avner ED: Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am J Physiol 275: F387-F394, 1998
50. Wang X, Gattone V 2nd, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 16: 846-851, 2005